SensoGenic

SensoGenic publicly describes its product as a handheld digital biosensor for food allergens, with a disposable sampling pad and a companion mobile workflow. The sensing concept is to capture allergenic proteins from a food sample, analyze them with a portable reader, and return a result that helps a user decide whether the food is safe to eat.

The company's public materials and coverage point to a nanotechnology-led approach built around cellulose-based capture chemistry, then a secondary identification step using antibodies. Early descriptions emphasized milk and eggs; later reporting framed the device as a broader consumer allergen detector for common allergens such as peanuts, tree nuts, wheat, soy, fish, and shellfish. In either case, the core value proposition is rapid pre-consumption screening rather than laboratory-grade testing after the fact.

Commercially, that places SensoGenic in the difficult intersection of consumer diagnostics, food safety, and low-cost point-of-use testing. The customer problem is real: allergy uncertainty is common in restaurants, shared kitchens, travel, and packaged foods, and the existing alternatives are either slower lab workflows or narrow single-allergen products. The company's edge would depend on whether it can prove reliable detection across messy real-world food matrices at a cost consumers will pay repeatedly for disposable pads.

The public evidence suggests an early-stage venture rather than a scaled platform: Tracxn describes the company as seed-stage, based in Rehovot, with a small team and modest funding, while CORDIS shows a Horizon 2020 feasibility project and a consumer-product development plan. That is meaningful validation of the technical idea, but not the same as broad market traction. Strategically, the company is more relevant to food-safety and biosensing diligence than to defense procurement or national-security programs.